Research To Practice | Oncology Videos

Latest Episodes:

Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series Nov 15, 2023

Show notes

Featuring perspectives from Prof Van Cutsem, including the following topics:

Introduction (0:00)
Case: A woman in her early 50s who has undergone the neoadjuvant CROSS regimen and received surgery experiences local recurrence of PD-L1-negative gastroesophageal junction (GEJ) adenocarcinoma while receiving adjuvant nivolumab — Priya Rudolph, MD, PhD (15:56)
Case: A man in his late 60s with localized Siewert Class III GEJ adenocarcinoma receives perioperative fluorouracil/leucovorin/oxaliplatin/docetaxel — Lai (Amber) Xu, MD, PhD (26:16)
Case: A woman in her early 90s who has undergone radiation therapy for esophageal squamous cell carcinoma now experiences local recurrence; PD-L1 combined positive score (CPS) is 71 — G Richard Polkinghorn, MD (36:33)
Case: A man in his late 60s with HER2-negative GEJ adenocarcinoma develops HER2-positive oligometastases — Matthew R Strickland, MD (42:17)
Case: A woman in her early 70s with metastatic HER2-positive gastroesophageal cancer who received first-line FOLFOX/trastuzumab now experiences disease progression; PD-L1 CPS is 10 — Henna Malik, MD (47:53)
Investigator Survey (52:26)

CME information and select publications

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series Nov 10, 2023

Show notes

Featuring perspectives from Dr Gail J Roboz, including the following topics:

Introduction (0:00)
Case: A man in his early 50s presents with fatigue and pancytopenia; bone marrow shows myelodysplastic syndromes (MDS) with 11% blasts; normal FISH MDS panel; next-generation sequencing shows BCOR, RUNX1 and UTAF1 mutations; normal metaphase cytogenetics — Warren S Brenner, MD (10:12)
Case: An African American woman in her early 60s with high-risk MDS receives oral decitabine/cedazuridine — Henna Malik, MD (16:39)
Case: A woman in her early 70s with anemia and low-grade MDS with ring sideroblasts experiences a poor response to erythropoietin and is now on luspatercept — Neil Morganstein, MD (22:15)
Case: A woman in her early 60s with newly diagnosed acute myeloid leukemia (AML) and a FLT3-ITD mutation receives 7 + 3 induction with midostaurin induction, consolidation, allogeneic transplant and maintenance — Amany R Keruakous, MD, MS (35:23)
Case: A man in his mid 60s with AML and an IDH1 mutation receives venetoclax/azacitidine/ivosidenib — Rebecca L Olin, MD, MSCE (53:23)
Case: A woman in her late 30s with refractory leiomyosarcoma develops anthracycline-related secondary AML with an IDH2 mutation and is unable to obtain foundation funding assistance for enasidenib copays — Eric H Lee, MD, PhD (56:48)

CME information and select publications

HER2-Positive and Triple-Negative Breast Cancer | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Featuring perspectives from Prof Mitesh J Borad, Dr Anthony El-Khoueiry, Dr Christopher R Flowers, Dr Sara A Hurvitz, Dr Thomas E Hutson, Dr Amrita Krishnan, Dr Ann S LaCasce, Dr Heather McArthur, Dr Bradley J Monk, Dr Kathleen N Moore, Dr Robert Z Orlowski and Dr Guru P Sonpavde, moderated by Dr Neil Love, co-moderated by Dr Stephen "Fred" Divers, including the following topics:

Introduction (0:00)
Triple-Negative Breast Cancer — Heather McArthur, MD, MPH (6:59)
HER2-Positive Breast Cancer — Sara A Hurvitz, MD, FACP (44:04)

CME information and select publications

Multiple Myeloma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Introduction (0:00)
Optimizing the Current Management of Multiple Myeloma — Robert Z Orlowski, MD, PhD (3:44)
CAR (Chimeric Antigen Receptor) T-Cell Therapy, Bispecific Antibodies and Other Novel Approaches — Amrita Krishnan, MD (32:37)

CME information and select publications

Gynecologic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Introduction (0:00)
Ovarian Cancer — Kathleen N Moore, MD, MS (4:14)
Endometrial and Cervical Cancers — Bradley J Monk, MD (41:09)

CME information and select publications

Hepatobiliary and Pancreatic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Introduction (0:00)
Biliary Tract and Pancreatic Cancer — Mitesh J Borad, MD (3:42)
Hepatocellular Carcinoma — Anthony El-Khoueiry, MD (33:25)

CME information and select publications

Urothelial Bladder Cancer and Renal Cell Carcinoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Introduction (0:00)
Renal Cell Carcinoma — Thomas E Hutson, DO, PharmD (6:19)
Urothelial Bladder Cancer — Guru P Sonpavde, MD (34:59)

CME information and select publications

Lymphoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Nov 03, 2023

Show notes

Introduction (0:00)
Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Ann S LaCasce, MD, MMSc (8:26)
Follicular Lymphoma and Mantle Cell Lymphoma — Christopher R Flowers, MD, MS (42:55)

CME information and select publications

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series Nov 02, 2023

Show notes

Featuring perspectives from Dr David M O'Malley, including the following topics:

Introduction: 2023 American Oncology Network Summit (0:00)
Case: A woman in her late 70s with metastatic BRCA wild-type, homologous recombination deficiency-negative high-grade serous ovarian cancer (HGSOC) experiences disease progression after 6 lines of systemic therapy; PS = 0 — Dana M Chase, MD (8:31)
Case: A woman in her mid 80s is diagnosed with a germline BRCA2 (gBRCA2) mutation and Stage IV HGSOC; CA-125 32,000 U/mL — Mamta Choksi, MD (21:27)
Case: A woman in her mid 40s who has undergone TAH/BSO for Stage IC HGSOC with a gBRCA2 mutation receives adjuvant carboplatin/paclitaxel — Priya Rudolph, MD, PhD (32:47)
Case: A woman in her early 60s with a gBRCA1 mutation and HGSOC who has undergone debulking surgery and carboplatin/paclitaxel develops anemia on maintenance olaparib — Karim ElSahwi, MD (40:56)
Case: A woman in her mid 60s with recurrent BRCA wild-type HGSOC is enrolled in a trial of tumor treating fields and paclitaxel — Lyndsay J Willmott, MD (54:01)
Case: A woman in her early 50s with multiregimen-recurrent FR-alpha-positive OC and a gBRCA1 mutation receives mirvetuximab soravtansine — Kellie E Schneider, MD (58:50)

CME information and select publications

Chronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute Oct 27, 2023

Show notes

Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics:

Introduction (0:00)
Chronic Lymphocytic Leukemia (CLL): Considerations for Front-Line Treatment — Dr Kahl (1:48)
Treatment of Relapsed/Refractory CLL; Novel and Investigational Strategies — Dr Chanan-Khan (35:38)
Clinical Questions and Cases (49:58)

CME information and select publications